Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Masimo Corp (MASI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,412,243
  • Shares Outstanding, K 53,337
  • Annual Sales, $ 858,290 K
  • Annual Income, $ 193,540 K
  • 60-Month Beta 1.12
  • Price/Sales 8.56
  • Price/Cash Flow 38.28
  • Price/Book 7.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.73
  • Number of Estimates 3
  • High Estimate 0.74
  • Low Estimate 0.73
  • Prior Year 0.73
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
125.50 +10.73%
on 04/25/19
147.91 -6.04%
on 05/16/19
+12.19 (+9.62%)
since 04/24/19
3-Month
118.93 +16.85%
on 04/18/19
147.91 -6.04%
on 05/16/19
+10.09 (+7.83%)
since 02/22/19
52-Week
96.14 +44.55%
on 07/30/18
147.91 -6.04%
on 05/16/19
+39.99 (+40.40%)
since 05/24/18

Most Recent Stories

More News
Globus Medical Reveals Positive Study Results for ExcelsiusGPS

Results of the study of ExcelsiusGPS reached a milestone for Globus Medical (GMED) in the field of robotics-assisted, minimally invasive pedicle screw placement procedure

GMED : 40.58 (+0.05%)
MASI : 138.97 (+0.91%)
XRAY : 53.75 (+0.02%)
CNMD : 81.43 (+0.54%)
Medtronic (MDT) Q4 Earnings Beat, Operating Margin Rises

Excluding the Diabetes group, Medtronic (MDT) displays better performances at CER on the back of growth in rest of the business segments and across all geographies.

MASI : 138.97 (+0.91%)
XRAY : 53.75 (+0.02%)
MDT : 93.03 (+2.44%)
CNMD : 81.43 (+0.54%)
Here's Why You Should Hold On to Integra LifeSciences Stock

Investor confidence is still high on growth prospects of Integra LifeSciences (IART).

IART : 48.96 (+0.23%)
MASI : 138.97 (+0.91%)
XRAY : 53.75 (+0.02%)
CNMD : 81.43 (+0.54%)
QIAGEN (QGEN) to Win U. N. Accolade for QuantiFERON-TB Access

This acclaim marks a giant leap for QIAGEN (QGEN) in the field of tuberculosis diagnosis.

MASI : 138.97 (+0.91%)
QGEN : 38.20 (-0.65%)
XRAY : 53.75 (+0.02%)
CNMD : 81.43 (+0.54%)
Hologic Breast Health Arm Aids Strongly, Rising Costs Ail

Within Breast Health, Hologic (HOLX) unveils a string of products including 3Dimensions and 3D Performance gantries, Clarity HD, SmartCurve, Affirm prone biopsy system and Brevera biopsy system.

HOLX : 44.69 (+0.02%)
MASI : 138.97 (+0.91%)
XRAY : 53.75 (+0.02%)
CNMD : 81.43 (+0.54%)
Will RTG Again Bolster Medtronic's (MDT) Earnings in Q4?

Within Neurovascular, we hope to witness strength across Medtronic's (MDT) stroke franchise with growth in stent retrievers, flow diverters, neuro access and embolic products.

MASI : 138.97 (+0.91%)
XRAY : 53.75 (+0.02%)
MDT : 93.03 (+2.44%)
CNMD : 81.43 (+0.54%)
ResMed Study Shows Remote Monitoring Benefits on CPAP Use

Results of this study mark a remarkable feat for ResMed's (RMD) medical innovation aimed at treating people suffering from sleep apnea.

RMD : 113.89 (+1.02%)
MASI : 138.97 (+0.91%)
XRAY : 53.75 (+0.02%)
CNMD : 81.43 (+0.54%)
Masimo Gets FDA Nod for Radius PPG, Boosts Patient Monitoring

Masimo (MASI) receives FDA 510 (k) clearance for Radius PPG, which is set to become an important breakthrough in patient monitoring.

MASI : 138.97 (+0.91%)
HAE : 101.01 (+1.98%)
CSII : 39.52 (+1.52%)
QDEL : 54.84 (+0.77%)
Avedro (AVDR) Hits a 52-Week High on Solid Growth Prospects

Avedro (AVDR) gains from promising developments in recent times.

MASI : 138.97 (+0.91%)
XRAY : 53.75 (+0.02%)
CNMD : 81.43 (+0.54%)
AVDR : 18.24 (-2.15%)
Varian Medical's CTSI Buyout to Boost Oncology Services Unit

The CTSI buyout is expected to prove accretive to Varian Medical's (VAR) adjusted earnings per share during fiscal 2021.

VAR : 128.07 (+0.68%)
MASI : 138.97 (+0.91%)
XRAY : 53.75 (+0.02%)
CNMD : 81.43 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade MASI with:

Business Summary

Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare...

See More

Key Turning Points

2nd Resistance Point 140.87
1st Resistance Point 139.92
Last Price 138.97
1st Support Level 137.84
2nd Support Level 136.71

See More

52-Week High 147.91
Last Price 138.97
Fibonacci 61.8% 128.13
Fibonacci 50% 122.03
Fibonacci 38.2% 115.92
52-Week Low 96.14

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar